Unknown

Dataset Information

0

Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.


ABSTRACT: To determine whether measuring antibodies against Epstein-Barr virus (EBV) glycoprotein gH/gL in serum could improve diagnostic accuracy in nasopharyngeal carcinoma (NPC) cases, gH/gL expressed in a recombinant baculovirus system was used in an enzyme-linked immunosorbent assay (ELISA) to detect antibodies in two independent cohorts. Binary logistic regression analyses were performed using results from a training cohort (n = 406) to establish diagnostic mathematical models, which were validated in a second independent cohort (n = 279). Levels of serum gH/gL antibodies were higher in NPC patients than in healthy controls (p < 0.001). In the training cohort, the IgA-gH/gL ELISA had a sensitivity of 83.7%, specificity of 82.3% and area under the curve (AUC) of 0.893 (95% CI, 0.862-0.924) for NPC diagnosis. Furthermore, gH/gL maintained diagnostic capacity in IgA-VCA negative NPC patients (sensitivity = 78.1%, specificity = 82.3%, AUC = 0.879 [95% CI, 0.820 - 0.937]). Combining gH/gL and viral capsid antigen (VCA) detection improved diagnostic capacity as compared to individual tests alone in both the training cohort (sensitivity = 88.5%, specificity = 97%, AUC = 0.98 [95% CI, 0.97 - 0.991]), and validation cohort (sensitivity = 91.2%, specificity = 96.5%, AUC = 0.97 [95% CI, 0.951-0.988]). These findings suggest that EBV gH/gL detection complements VCA detection in the diagnosis of NPC and aids in the identification of patients with VCA-negative NPC.

SUBMITTER: Li RC 

PROVIDER: S-EPMC4941321 | biostudies-other | 2016 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.

Li Rui-Chen RC   Du Yong Y   Zeng Qiu-Yao QY   Tang Lin-Quan LQ   Zhang Hua H   Li Yan Y   Liu Wan-Li WL   Zhong Qian Q   Zeng Mu-Sheng MS   Huang Xiao-Ming XM  

Oncotarget 20160301 13


To determine whether measuring antibodies against Epstein-Barr virus (EBV) glycoprotein gH/gL in serum could improve diagnostic accuracy in nasopharyngeal carcinoma (NPC) cases, gH/gL expressed in a recombinant baculovirus system was used in an enzyme-linked immunosorbent assay (ELISA) to detect antibodies in two independent cohorts. Binary logistic regression analyses were performed using results from a training cohort (n = 406) to establish diagnostic mathematical models, which were validated  ...[more]

Similar Datasets

| S-EPMC11369822 | biostudies-literature
| S-EPMC3012493 | biostudies-literature
| S-EPMC7050088 | biostudies-literature
| S-EPMC8953146 | biostudies-literature
| S-EPMC5543490 | biostudies-literature
| S-EPMC10177259 | biostudies-literature
| S-EPMC5355600 | biostudies-literature
| S-EPMC4655226 | biostudies-literature
| S-EPMC7247807 | biostudies-literature
| S-EPMC6230770 | biostudies-literature